| Catalog number: | bs-11708R-Cy7 |
|---|---|
| Price: | 612 € |
| Supplier: | abebio |
| Product name: | PARK9/ATP13A2 Antibody, Cy7 Conjugated |
| Quantity: | 1x plate of 96 wells |
| Related search: |
| Long name: | Cy7 Conjugated, PARK9/ATP13A2 Polyclonal Antibody |
|---|---|
| Category: | Conjugated Primary Antibodies |
| Conjugation: | Cy7 |
| Host Organism: | Rabbit (Oryctolagus cuniculus) |
| Target Antigen: | PARK9/ATP13A2 |
| Specificity: | This is a highly specific antibody against PARK9/ATP13A2 |
| Modification: | Unmodified |
| Modification site: | None |
| Clonality: | Polyclonal |
| Clone: | Polyclonal antibody |
| Concentration: | 1ug per 1ul |
| Subcellular location: | Extracellular |
| Source: | KLH conjugated synthetic peptide derived from human ATP13A2 |
| Tested applications: | IF(IHC-P) |
| Recommended dilutions: | IF(IHC-P)(1:50-200) |
| Crossreactivity: | Mouse, Rat, Human |
| Crossreactive species details: | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Antigen background: | ATP13A2 functions to catalyze the conversion of ATP to ADP and a free phosphate, Defects in the gene encoding ATP13A2 are the cause of Kufor-Rakeb syndrome (KRS), Expressed as multiple alternative spliced isoforms, The ATP13A2 gene maps to human chromosome 1, a rare hereditary type of Parkinsonâ, contains over 3, thereby participating in the active transport of ions across cellular membranes, which spans 260 million base pairs, &euro, &trade, 000 genes and comprises nearly 8% of the human genome, 180 amino acid multi-pass membrane protein that belongs to the P5 subfamily of ATPases which play an important role in the transportation of inorganic cations, ATP13A2 is a 1, s disease that exhibits juvenile onset and is characterized by neurodegeneration and dementia |
| Purification method: | This antibody was purified via Protein A |
| Storage conditions: | 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA |
| Excitation Emission: | 743nm/767nm |
| Synonyms: | HSA9947 CLN12 |
| Properties: | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24° |
| Conjugated: | These antibodies are excite for emission at 650 nm and detected at a 676 nm wavelengths |
| Gene target: | PARK9/ATP13A2 Conjugated |
| Short name: | Conjugated, PARK9/ATP13A2 Antibody |
| Technique: | antibodies against human proteins, antibodies for, antibody Conjugates, Antibody |
| Label: | Cy7 |
| Alternative name: | cyanine 7 coupled, PARK9/ATP13A2 (Antibody to) |
| Alternative technique: | antibodies |
| Identity: | 30213 |
| Gene: | ATP13A2 | More about : ATP13A2 |
| Long gene name: | ATPase 13A2 |
| Synonyms gene: | PARK9 |
| Synonyms gene name: | Parkinson disease (autosomal recessive) 9 (Kufor-Rakeb syndrome) ATPase type 13A2 |
| Locus: | 1p36, 13 |
| Discovery year: | 2005-01-12 |
| GenBank acession: | AL354615 |
| Entrez gene record: | 23400 |
| Pubmed identfication: | 15381061 16964263 |
| RefSeq identity: | NM_022089 |
| Classification: | Parkinson disease associated genes ATPase orphan transporters |
| Havana BLAST/BLAT: | OTTHUMG00000002293 |
| Locus Specific Databases: | LRG_834 |
| bs-11708R-Cy7 | PARK9/ATP13A2 Antibody, Cy7 Conjugated | 0.1ml | 350 € | Bioss Primary Conjugated Antibodies | human |
| bs-11708R-Biotin | PARK9/ATP13A2 Antibody, Biotin Conjugated | 0.1ml | 333 € | Bioss Primary Conjugated Antibodies | human |
| bs-11708R-Cy3 | PARK9/ATP13A2 Antibody, Cy3 Conjugated | 0.1ml | 350 € | Bioss Primary Conjugated Antibodies | human |
| bs-11708R-Cy5 | PARK9/ATP13A2 Antibody, Cy5 Conjugated | 0.1ml | 350 € | Bioss Primary Conjugated Antibodies | human |
| bs-11708R-Cy5.5 | PARK9/ATP13A2 Antibody, Cy5.5 Conjugated | 0.1ml | 350 € | Bioss Primary Conjugated Antibodies | human |
| bs-11708R-FITC | PARK9/ATP13A2 Antibody, FITC Conjugated | 0.1ml | 333 € | Bioss Primary Conjugated Antibodies | human |
| bs-11708R-HRP | PARK9/ATP13A2 Antibody, HRP Conjugated | 0.1ml | 350 € | Bioss Primary Conjugated Antibodies | human |
| AP50292PU-N | anti-ATP13A2 / PARK9 (C-term) Antibody | 0,4 ml | 587 € | acr | human |
| bs-11708R-A350 | PARK9/ATP13A2 Antibody, ALEXA FLUOR 350 | 100ul | 332 € | Bioss Primary Conjugated Antibodies. | human |
| bs-11708R-A488 | PARK9/ATP13A2 Antibody, ALEXA FLUOR 488 | 100ul | 332 € | Bioss Primary Conjugated Antibodies. | human |
| bs-11708R-A555 | PARK9/ATP13A2 Antibody, ALEXA FLUOR 555 | 100ul | 332 € | Bioss Primary Conjugated Antibodies. | human |
| bs-11708R-A594 | PARK9/ATP13A2 Antibody, ALEXA FLUOR 594 | 100ul | 332 € | Bioss Primary Conjugated Antibodies. | human |
| bs-11708R-A647 | PARK9/ATP13A2 Antibody, ALEXA FLUOR 647 | 100ul | 332 € | Bioss Primary Conjugated Antibodies. | human |
| bs-11708R | PARK9/ATP13A2 Antibody | 0.1ml | 263 € | Bioss Primary Unconjugated Antibodies | human |
| GENTAUR-58be5b997755f | Anti-PARK9/ATP13A2 (Polyclonal), ALEXA Fluor 594 | 100 microliters | 489 € | Bioss Polyclonal Antibodies | human |
| GENTAUR-58bdfe6edd9bc | Anti- ATP13A2 Antibody | 0.06 ml | 265 € | MBS Polyclonals | human |
| GENTAUR-58bdfe6f9d5e6 | Anti- ATP13A2 Antibody | 0.12 ml | 348 € | MBS Polyclonals | human |
| MBS610679 | ATPase Type 13A2 (ATP13A2, Probable Cation-transporting ATPase 13A2) Antibody | 100ul | 597 € | MBS Polyclonals_1 | human |
| MBS611954 | ATPase Type 13A2 (ATP13A2, Probable Cation-transporting ATPase 13A2) Antibody | 100ul | 652 € | MBS Polyclonals_1 | human |
| MBS618888 | ATPase Type 13A2 (ATP13A2, Probable Cation-transporting ATPase 13A2) Antibody | 100ul | 652 € | MBS Polyclonals_1 | human |
| abx908515 | Anti-ATP13A2 siRNA | inquire | 50 € | abbex | human |
| abx908516 | Anti-ATP13A2 siRNA | inquire | 50 € | abbex | human |
| LV085330 | ATP13A2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) | 1.0 µg DNA | 322 € | ABM lentivectors | human |
| LV085331 | ATP13A2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA) | 1.0 µg DNA | 322 € | ABM lentivectors | human |
| LV085332 | ATP13A2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) | 1.0 µg DNA | 322 € | ABM lentivectors | human |
| LV085333 | ATP13A2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) | 1.0 µg DNA | 322 € | ABM lentivectors | human |
| LV085335 | ATP13A2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) | 1.0 µg DNA | 322 € | ABM lentivectors | human |
| LV085334 | ATP13A2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) | 1.0 µg DNA | 322 € | ABM lentivectors | human |
| AE55153HU-48 | ELISA test for Human Probable cation-transporting ATPase 13A2 (ATP13A2) | 1x plate of 48 wells | 373 € | abebio | human |
| AE55153HU-96 | Human Probable cation-transporting ATPase 13A2 (ATP13A2) ELISA Kit | 1x plate of 96 wells | 612 € | abebio | human |